POSITive
Unknown
265 enrolled
CRISTINA
Unknown
72 enrolled
Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy
Unknown
150 enrolled
MELCAYA
Unknown
70 enrolled
Melanoma
Unknown
20 enrolled
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
Unknown
100 enrolled
Community Based Strategies for Early Detection of Melanoma
Unknown
200 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
Unknown
425 enrolled
CANINE
Unknown
500 enrolled
TRIM
Unknown
1,000 enrolled
EXOMEL1
Unknown
150 enrolled
The Prognostic Value of 18F-PFPN PET Imaging in Patients With Malignant Melanoma
Unknown
100 enrolled
Microbiome Immunotherapy Toxicity and Response Evaluation
Unknown
1,800 enrolled
Helioma
Unknown
100 enrolled
A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer
Unknown
180 enrolled
Blood Vessel Patterns in Small Choroidal Tumors
Unknown
15 enrolled
Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis
Unknown
18 enrolled
Conservative Nodal Surgery (Node-picking) of Patients With Stage III Melanoma With Low-burden of Nodal Disease (MELCONSURG MULTICENTRE COHORT)
Unknown
68 enrolled
ISABELLA
Unknown
1,570 enrolled
RATIONALE
Unknown
500 enrolled
DERMOCTAV
Unknown
150 enrolled
GI Complications in Cancer Immunotherapy Patients
Unknown
100 enrolled
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
Unknown
80 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
ICIPRESIST19
Unknown
350 enrolled
ANTIPRAME
Unknown
55 enrolled
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
Unknown
152 enrolled
HSP70CTC
Unknown
120 enrolled
Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors
Unknown
400 enrolled
Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor.
Unknown
300 enrolled
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
Unknown
100 enrolled
ICIT
Unknown
200 enrolled
PIONEER
Unknown
1,000 enrolled
The Aim of This Study is to Demonstrat That Vacuum-assisted Closure Versus Conventional Wound Closure Enables to Diminish Local Complications After Lymph Node Dissection in Patients With Metastatic Skin Tumors
Unknown
90 enrolled
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Unknown
130 enrolled
PRIMM
Unknown
450 enrolled
ICI-DISCOVER
Unknown
200 enrolled
Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Unknown
800 enrolled
Polish Microbiome Map
Unknown
1,160 enrolled
Immune Monitoring in Metastatic Melanoma
Unknown
100 enrolled
Real World Study of Four PD-1 Agents in China
Unknown
500 enrolled
M3
Unknown
2,000 enrolled
ILI
Unknown
40 enrolled
PADAONCODERM
Unknown
150 enrolled
EXPEVIVO-CTC
Unknown
450 enrolled
Circulating Tumor DNA Exposure in Peripheral Blood
Unknown
10,000 enrolled
NNCD
Unknown
80 enrolled
Early Diagnosis of Malignant Transformation of Pigmentary Skin Lesions
Unknown
20 enrolled
IMINEM
Unknown
186 enrolled